Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires
Recruiting · NCT01501838 · Observational (researchers observe without assigning treatment) · Lead sponsor: Hospital Italiano de Buenos Aires
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.
Who can take part
Age range
17 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Diagnosed with PAH WHO group 1 (2022 ESC/ESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) \>15 mmHg and pulmonary vascular resistance (PVR) \>2 WU, according to the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
- Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires
- Aged ≥18 years at the index date.
Exclusion criteria
- History of lung transplantation surgery previously the baseline period
Where it is running
1 location listed.
- Hospital Italiano de Buenos Aires - Buenos Aires, Buenos Aires, Argentina